5‐ASA vs control (all trials)
Number of participants with adverse events (epigastric pain, nausea, diarrhoea) · patients with the need for management of diverticulitis
5‐ASA showed no clear difference in number of participants with adverse events (epigastric pain, nausea,… compared with control (all trials) (moderate certainty).
1 finding from 1 review
- Mesalamine (5‐ASA) for the prevention of recurrent diverticulitis 2017 · Cochrane Headline outcomes onlyRR 0.98 [0.91, 1.06]5 studies · 1421 participantsModerate